Pacific Biosciences
PACB
PACB
222 hedge funds and large institutions have $265M invested in Pacific Biosciences in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 73 reducing their positions, and 35 closing their positions.
Holders
222
Holders Change
-3
Holders Change %
-1.33%
% of All Funds
3.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
36
Increased
57
Reduced
73
Closed
35
Calls
$4.29M
Puts
$1.73M
Net Calls
+$2.56M
Net Calls Change
-$95K
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$2.6M |
| 2 |
2
Bank of New York Mellon
New York
|
$1.02M |
| 3 |
3
Walleye Capital
New York
|
$0 |
| 4 |
4
Goldman Sachs
New York
|
$2.2M |
| 5 |
5
Morgan Stanley
New York
|
$3.98M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OP
251
ORG Partners
Roanoke,
Indiana
| – | -$184 | -101 | Closed |
|
252
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$37 | -20 | Closed |
|